Public Health Trace republishes official recall, outbreak, and surveillance data from CDC, FDA, USDA, WHO, and other public sources. It is an independent information service, not a medical provider, and not a substitute for professional medical advice or your local public health department's own guidance.
Please review the following before continuing:
Policy version 2026-07-21, effective July 21, 2026.
United States
TerminatedClass II
Nestle Health Science (NHS U.S., LLC) is initiating a recall of Douglas Labs Stress-B-Plus Dietary Supplement Tablets, 90 tablets per bottle. The bottle is white and made of plastic. Lot Numbers 50335944,50344396, expiration date 04/11/2026. The product is being recalled because of Incorrect formulation manufactured vs label claims. Product was manufactured with Niacin (as Nicotinic acid) and supplement facts panel states contains Niacin (as Niacinamide).
| Product description | UPC | Quantity | Lot / code information |
|---|---|---|---|
| Douglas Labs Stress-B-Plus Dietary Supplement, Tablets, 90 tablets per bottle. UPC # 10539 97452, Lot Numbers ,50335944 and 50344396. Expiration Date 04/11/2026 | Not published in this source record | 3,269 bottles in market | Lot Codes: 50335944, 50344396 |
Responsible company: Nestle Product Technology Center - Nestle Health Science
FDA Recall United States Terminated Historical recordClass III
A map highlighting the states named in the source's distribution description.
Shading reflects state-level totals only, as published by the source. It does not imply county-level or point-level precision.
| State | Distributed |
|---|---|
| Alaska | 1 |
| Arizona | 1 |
| California | 1 |
| Colorado | 1 |
| Delaware | 1 |
| Florida | 1 |
| Georgia | 1 |
| Iowa | 1 |
| Idaho | 1 |
| Illinois | 1 |
| Indiana | 1 |
| Kansas | 1 |
| Kentucky | 1 |
| Louisiana | 1 |
| Massachusetts | 1 |
| Maryland | 1 |
| Michigan | 1 |
| Minnesota | 1 |
| Missouri | 1 |
| North Carolina | 1 |
| New Hampshire | 1 |
| New Jersey | 1 |
| New Mexico | 1 |
| New York | 1 |
| Ohio | 1 |
| Oklahoma | 1 |
| Oregon | 1 |
| Pennsylvania | 1 |
| South Dakota | 1 |
| Tennessee | 1 |
| Texas | 1 |
| Virginia | 1 |
| Washington | 1 |
| Wisconsin | 1 |
| West Virginia | 1 |
States shown are extracted from the source's free-text distribution description above; a narrative description (e.g. "distributed nationwide") may not list individual states to extract.
View FDA enforcement record -- the specific openFDA record this summary was built from.
No separate FDA public notice was found for this enforcement record. The information below comes from FDA's Recall Enterprise System through openFDA.
FDA Enforcement Reports -- FDA's general, official recall and enforcement information.
View raw source data -- the machine-readable record this page's information was built from.
Retrieved by Public Health Trace:
A situation in which use of or exposure to a product may cause temporary or medically reversible adverse health consequences, or where the probability of serious consequences is remote.
According to FDA, this recall's status is "Terminated." Always confirm the current status using the source links below, since status can change after Public Health Trace last retrieved this record.
Follow the instructions published by the responsible agency (see the source links below) -- recall guidance (e.g. dispose of the product, return it for a refund, or check for a specific lot number) varies by recall and is set by that agency, not by Public Health Trace.
The source links below, published by FDA, are the authoritative record for this recall, including any updates issued after this summary was retrieved.
This summary is based on the official source record referenced above. Public Health Trace does not state that any company or product is unsafe beyond what the official source has published. Read the full medical disclaimer.
